TRAF7-Targeted HOXA5 Acts as a Tumor Suppressor in Prostate Cancer Progression and Stemness via Transcriptionally Activating SPRY2 and Regulating MEK/ERK Signaling

Researchers identified the downregulation of HOXA5 in prostate cancer (PCa) tissues based on the TCGA database and further verified in 30-paired PCa and adjacent normal tissues.